STOCK TITAN
  1. Home
  2. News
  3. CRKN

Crown ElectroKinetics Corp. - $CRKN STOCK NEWS

Welcome to our dedicated page for Crown ElectroKinetics news (Ticker: $CRKN), a resource for investors and traders seeking the latest updates and insights on Crown ElectroKinetics stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Crown ElectroKinetics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Crown ElectroKinetics's position in the market.

News
Crown Electrokinetics Executes Master Services Agreement with New Customer
Rhea-AI Summary
Crown Electrokinetics Corp. announces Mater Services Agreement with a large US contractor for two projects in Arizona with potential revenue of up to $70 million. Company expects to grow in Arizona by adding more personnel and equipment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
none
-
News
Crown Electrokinetics Reminds Investors of Conference Call on September 18th
Rhea-AI Summary
Crown Electrokinetics Corp. will hold an investor update conference call on September 18, 2023. Shareholders are encouraged to submit questions. Conference call replay information is also provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.93%
Tags
none
-
News
Crown Electrokinetics Completes Purchase of New Micro Trenchers
Rhea-AI Summary
Crown Electrokinetics Corp. announces order for new micro trenchers to be deployed with a new customer in Arizona.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.18%
Tags
none
News
Crown Electrokinetics Regains Compliance with Nasdaq Listing Requirements
Rhea-AI Summary
Crown Electrokinetics Corp. regains compliance with Nasdaq's listing rules and eliminates nearly all of its debt.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.68%
Tags
none
-
News
Crown Electrokinetics to Host Investor Conference Call on September 18, 2023 at 4:30 p.m. Est
Rhea-AI Summary
Crown Electrokinetics Corp. (NASDAQ:CRKN) announced investor update conference call on September 18, 2023 featuring remarks by CEO and CFO.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.25%
Tags
conferences
-
News
Crown Electrokinetics Provides Second Quarter Business Update
Rhea-AI Summary
Crown Electrokinetics Corp. addresses concerns over declining stock price, plans to investigate potential unlawful trading practices. The company is acquiring new micro trenching equipment to improve construction capabilities. Addition of new senior executives expected to attract new customers. Recent additions to the board of directors provide guidance in the commercial real estate industry. Earnings delay due to complex transactions for NASDAQ compliance plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.42%
Tags
none
News
Crown Electrokinetics Appoints Scott Hobbs to Board of Directors
Rhea-AI Summary
Crown Electrokinetics Corp. adds Scott Hobbs to its board of directors. Hobbs' expertise in office tenant representation is expected to benefit the commercialization of Crown's Smart Window Inserts. CFO Joel Krutz also appointed to the board.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.3%
Tags
management
-
News
Crown Electrokinetics Issues Letter to Shareholders
Rhea-AI Summary
Crown Electrokinetics Corp. has successfully eliminated all October and January notes, completed a required reverse stock split, and filed an S-1 as part of their plan to regain compliance with NASDAQ listing requirements. The process has been costly and challenging, but the company is now in a better position to move forward with their fiber optic construction and electrokinetic film businesses. They have bolstered their fiber optics organization with two senior executive hires and are acquiring specialized equipment for the 5G construction industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.82%
Tags
none
-
News
Crown Electrokinetics Announces 1-for-60 Reverse Stock Split
Rhea-AI Summary
Crown Electrokinetics Corp. (NASDAQ:CRKN) announces a 1-for-60 reverse stock split on its common stock effective August 14, 2023. Trading on a split-adjusted basis begins on August 15, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-24.14%
Tags
none
News
Crown Electrokinetics Welcomes Telecommunication Veterans David Martinez and Mike Sullivan to Fiber Optics Division
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.57%
Tags
none
Stock CRKN logo
Crown ElectroKinetics Corp.

Nasdaq:CRKN

CRKN Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

CRKN Stock Data

8.84M
51.31M
0.7%
1.29%
0.31%
Other Electronic Component Manufacturing
Manufacturing
Link
United States of America
CORVALLIS

About CRKN

crown electrokinetics (otcqb: crkn) a global leader in dynamictint - we make your glass smarter™. originally invented by hewlett-packard (hp, inc.), our technology allows any glass surface to transition between clear and dark in seconds. dynamictint™allows windows to transition from transparent to black. with applications to a wide array of windows, including commercial buildings, automotive sunroofs, and residential skylights, crown partners with leading glass and film manufacturers, licensing its intellectual property for mass production. at the core of crown’s technology is a thin film that is powered by electrically-charged pigment which not only replaces common window tints but is also a more sustainable alternative to traditional window treatments. the company is supported by a robust patent portfolio.